CDC Panel Discusses Whether to Offer Boosters to Children 5
Scientific advisors to the Centers for Disease Control and Prevention will meet on Thursday to discuss whether to recommend a third dose of the Pfizer-BioNTech vaccine to children ages 5 to 11. The Food and Drug Administration authorized the booster shot for this age group on Tuesday. CDC consultants are also expected to approve the …
Continue reading “CDC Panel Discusses Whether to Offer Boosters to Children 5”